ANI Pharmaceuticals, Inc.
DE ˙ DB ˙ US00182C1036
54,50 € 0,00 (0,00%)
2023-08-21
DEL PRIS
SecurityDE:BSFA / ANI Pharmaceuticals, Inc.
InstitutionMorgan Stanley
Latest Disclosed Ownership219,845 shares
Latest Disclosed Value $ 16,906,207
Morgan Stanley reports 21.88% decrease in ownership of BSFA / ANI Pharmaceuticals, Inc.

On May 15, 2026 - Morgan Stanley filed a 13F-HR form disclosing ownership of 219,845 shares of ANI Pharmaceuticals, Inc. (DE:BSFA) valued at $16,906,207 USD as of March 31, 2026. The entity filed a previous 13F-HR/A on May 27, 2026 disclosing 281,427 shares of ANI Pharmaceuticals, Inc.. This represents a change in shares of -21.88% during the quarter. The current value of the position is $11,981,552 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F ANI PHARMACEUTICALS COM 00182C103 219,845 -61,582 -21.88 16,906 -23.90 0.0010
2026-05-27 2025-12-31 13F/A-1 ANI PHARMACEUTICALS COM 00182C103 281,427 49,401 21.29 22,216 4.53 0.0013
2026-02-13 2025-12-31 13F ANI PHARMACEUTICALS COM 00182C103 281,427 49,401 22,216
2026-05-27 2025-09-30 13F/A-1 ANI PHARMACEUTICALS COM 00182C103 232,026 31,150 15.51 21,254 62.15 0.0013
2025-11-14 2025-09-30 13F ANI PHARMACEUTICALS COM 00182C103 232,026 31,150 21,254 0.0013
2025-08-15 2025-06-30 13F ANI PHARMACEUTICALS COM 00182C103 200,876 -236,577 -54.08 13,107 -55.25 0.0009
2025-05-15 2025-03-31 13F ANI PHARMACEUTICALS COM 00182C103 437,453 210,875 93.07 29,288 133.83 0.0021
2025-05-15 2024-12-31 13F/A-1 ANI PHARMACEUTICALS COM 00182C103 226,578 -174,751 -43.54 12,525 -47.69 0.0009
2025-02-14 2024-12-31 13F ANI PHARMACEUTICALS COM 00182C103 226,578 -174,751 12,525 0.0009
2025-05-14 2024-09-30 13F/A-2 ANI PHARMACEUTICALS COM 00182C103 401,329 130,990 48.45 23,943 39.08 0.0017
2025-02-14 2024-09-30 13F/A-1 ANI PHARMACEUTICALS COM 00182C103 401,329 130,990 23,943 0.0017
2024-11-14 2024-09-30 13F ANI PHARMACEUTICALS COM 00182C103 401,329 130,990 23,943 0.0017
2025-05-14 2024-06-30 13F/A-2 ANI PHARMACEUTICALS COM 00182C103 270,339 18,079 7.17 17,215 -1.28 0.0013
2024-10-17 2024-06-30 13F/A-1 ANI PHARMACEUTICALS COM 00182C103 270,339 18,079 17,215 0.0013
2024-08-14 2024-06-30 13F ANI PHARMACEUTICALS COM 00182C103 270,339 18,079 17,215 0.0013
2024-10-17 2024-03-31 13F/A-2 ANI PHARMACEUTICALS COM 00182C103 252,260 20,317 8.76 17,439 36.35 0.0014
2024-08-16 2024-03-31 13F/A-1 ANI PHARMACEUTICALS COM 00182C103 252,260 20,317 17,439 0.0002
2024-05-15 2024-03-31 13F ANI PHARMACEUTICALS COM 00182C103 252,260 20,317 17,439 0.0014
2024-08-16 2023-12-31 13F/A-1 ANI PHARMACEUTICALS COM 00182C103 231,943 12,290 5.60 12,789 0.28 0.0011
2024-02-13 2023-12-31 13F ANI PHARMACEUTICALS COM 00182C103 231,943 12,290 12,789 0.0011
2023-11-15 2023-09-30 13F ANI PHARMACEUTICALS COM 00182C103 219,653 37,820 20.80 12,753 30.29 0.0013
2023-08-14 2023-06-30 13F ANI PHARMACEUTICALS COM 00182C103 181,833 77,692 74.60 9,788 136.65 0.0010
2023-05-15 2023-03-31 13F ANI PHARMACEUTICALS COM 00182C103 104,141 2,929 2.89 4,136 1.60 0.0004
2023-02-14 2022-12-31 13F ANI PHARMACEUTICALS COM 00182C103 101,212 -19,645 -16.25 4,072 4.81 0.0005
2022-11-14 2022-09-30 13F ANI PHARMACEUTICALS COM 00182C103 120,857 5,323 4.61 3,884 13.27 0.0005
2022-10-27 2022-06-30 13F/A-1 ANI PHARMACEUTICALS COM 00182C103 115,534 69,280 149.78 3,429 163.77 0.0004
2022-08-15 2022-06-30 13F ANI PHARMACEUTICALS COM 00182C103 115,534 69,280 3,429 0.0001
2022-10-27 2022-03-31 13F/A-1 ANI PHARMACEUTICALS COM 00182C103 46,254 3,252 7.56 1,300 -34.38 0.0002
2022-05-13 2022-03-31 13F ANI PHARMACEUTICALS COM 00182C103 46,254 3,252 1,300 0.0002
2022-02-14 2021-12-31 13F ANI PHARMACEUTICALS COM 00182C103 43,002 -53,940 -55.64 1,981 -37.72 0.0002
2021-11-15 2021-09-30 13F ANI PHARMACEUTICALS COM 00182C103 96,942 -9,476 -8.90 3,181 -14.72 0.0004
2021-08-23 2021-06-30 13F/A-1 ANI PHARMACEUTICALS COM 00182C103 106,418 -2,360 -2.17 3,730 -5.14 0.0005
2021-08-16 2021-06-30 13F ANI PHARMACEUTICALS COM 00182C103 106,418 -2,360 3,730 0.0001
2021-05-17 2021-03-31 13F ANI PHARMACEUTICALS COM 00182C103 108,778 -50,828 -31.85 3,932 -15.17 0.0006
2021-02-16 2020-12-31 13F ANI PHARMACEUTICALS COM 00182C103 159,606 33,370 26.43 4,635 30.16 0.0007
2020-11-13 2020-09-30 13F ANI PHARMACEUTICALS COM 00182C103 126,236 -13,178 -9.45 3,561 -21.04 0.0007
2020-08-14 2020-06-30 13F ANI PHARMACEUTICALS COM 00182C103 139,414 114,430 458.01 4,510 343.03 0.0010
2020-05-26 2020-03-31 13F/A-1 ANI PHARMACEUTICALS COM 00182C103 24,984 -21,402 -46.14 1,018 -64.42 0.0003
2020-05-15 2020-03-31 13F ANI PHARMACEUTICALS COM 00182C103 24,984 -21,402 1,018 78.2036
2020-02-14 2019-12-31 13F ANI PHARMACEUTICALS COM 00182C103 46,386 13,761 42.18 2,861 20.31 0.0007
2019-11-14 2019-09-30 13F ANI PHARMACEUTICALS COM 00182C103 32,625 -6,619 -16.87 2,378 -26.29 0.0006
2019-08-14 2019-06-30 13F ANI PHARMACEUTICALS COM 00182C103 39,244 33,208 550.17 3,226 657.28 0.0009
2019-05-15 2019-03-31 13F ANI PHARMACEUTICALS COM 00182C103 6,036 -8,535 -58.58 426 -35.06 0.0001
2019-02-14 2018-12-31 13F ANI PHARMACEUTICALS COM 00182C103 14,571 -693 -4.54 656 -24.07 0.0002
2019-04-23 2018-09-30 13F/A-2 ANI PHARMACEUTICALS COM 00182C103 15,264 -41,404 -73.06 864 -77.18 0.0002
2018-11-20 2018-09-30 13F/A-1 ANI PHARMACEUTICALS COM 00182C103 15,264 0 864 0.0002
2018-11-14 2018-09-30 13F ANI PHARMACEUTICALS COM 00182C103 15,264 -41,404 864
2019-04-23 2018-06-30 13F/A-1 ANI PHARMACEUTICALS COM 00182C103 56,668 32,715 136.58 3,786 171.40 0.0010
2018-08-14 2018-06-30 13F ANI PHARMACEUTICALS COM 00182C103 56,668 32,715 3,786
2019-04-23 2018-03-31 13F/A-1 ANI PHARMACEUTICALS COM 00182C103 23,953 -16,336 -40.55 1,395 -46.28 0.0004
2018-05-14 2018-03-31 13F ANI PHARMACEUTICALS COM 00182C103 23,953 -16,336 1,395
2019-04-23 2017-12-31 13F/A-1 ANI PHARMACEUTICALS COM 00182C103 40,289 -8,851 -18.01 2,597 0.66 0.0007
2018-02-14 2017-12-31 13F ANI PHARMACEUTICALS COM 00182C103 40,289 -8,851 2,597
2017-11-14 2017-09-30 13F ANI PHARMACEUTICALS COM 00182C103 49,140 -27,367 -35.77 2,580 -27.91 0.0008
2017-08-11 2017-06-30 13F ANI PHARMACEUTICALS COM 00182C103 76,507 59,936 361.69 3,579 335.93 0.0011
2017-05-22 2017-03-31 13F/A-1 ANI PHARMACEUTICALS COM 00182C103 16,571 -12,325 -42.65 821 -53.14 0.0003
2017-05-12 2017-03-31 13F ANI PHARMACEUTICALS COM 00182C103 16,571 821
2017-02-22 2016-12-31 13F/A-1 ANI PHARMACEUTICALS COM 00182C103 28,896 -22,085 -43.32 1,752 -48.20 0.0006
2017-02-13 2016-12-31 13F ANI PHARMACEUTICALS COM 00182C103 28,896 1,752
2016-11-10 2016-09-30 13F ANI PHARMACEUTICALS COM 00182C103 50,981 47,842 1,524.12 3,382 1,821.59 0.0012
2016-08-12 2016-06-30 13F ANI PHARMACEUTICALS COM 00182C103 3,139 -24,758 -88.75 176 -81.26 0.0001
2016-05-12 2016-03-31 13F ANI PHARMACEUTICALS COM 00182C103 27,897 20,142 259.73 939 168.29 0.0004
2016-02-09 2015-12-31 13F ANI PHARMACEUTICALS COM 00182C103 7,755 -11,858 -60.46 350 -54.84 0.0001
2016-02-08 2015-09-30 13F/A-1 ANI PHARMACEUTICALS COM 00182C103 19,613 2,608 15.34 775 -26.61 0.0003
2015-11-09 2015-09-30 13F ANI PHARMACEUTICALS COM 00182C103 19,613 775
2015-08-12 2015-06-30 13F ANI PHARMACEUTICALS COM 00182C103 17,005 -60,231 -77.98 1,056 -78.15 0.0004
2015-05-14 2015-03-31 13F ANI PHARMACEUTICALS COM 00182C103 77,236 -24,744 -24.26 4,832 -15.98 0.0018
2015-02-13 2014-12-31 13F ANI PHARMACEUTICALS COM 00182C103 101,980 73,999 264.46 5,751 627.05 0.0021
2014-12-16 2014-09-30 13F/A-1 ANI PHARMACEUTICALS COM 00182C103 27,981 -100,276 -78.18 791 -82.09 0.0003
2014-11-14 2014-09-30 13F ANI PHARMACEUTICALS COM 00182C103 27,981 791
2014-08-12 2014-06-30 13F ANI PHARMACEUTICALS COM 00182C103 128,257 74,966 140.67 4,417 164.49 0.0076
2014-05-13 2014-03-31 13F ANI PHARMACEUTICALS COM 00182C103 53,291 27,971 110.47 1,670 228.09 0.0007
2014-02-13 2013-12-31 13F ANI PHARMACEUTICALS COM 00182C103 25,320 25,320 509 0.0002
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.